Szpital Specjalistyczny Im. Stefana Żeromskiego Samodzielny Publiczny Zakład Opieki Zdrowotnej w Krakowie Z.O.Z.

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2001-08-14
Activity description

Szpital Specjalistyczny Im. Stefana Żeromskiego Sa operates hospital departments and outpatient clinics, including ophthalmology, where it admits both children and adults and provides diagnosis and treatment. It performs MRI scans using a Siemens MAGNETOM Sola 1.5 T scanner. It is rebuilding the entrance to its gynecology and obstetrics department to improve access for people with disabilities and reduced mobility.

Registered address
os. Na Skarpie 66, 31-913 Kraków, Poland
Email
Phone
Electronic delivery address
AE:PL-49109-84311-TTFHV-13

Financials

Revenue history (in m)

Filing timeliness

No financial statement for 2025 – the filing deadline has passed. 2 of 6 financial statements not filed.

  • 2025not filed
  • 2024filed
  • 2023filed
  • 2022filed
  • 2021not filed
  • 2020not filed
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2024.

Voivodeship · Małopolskie257 / 46,049
Top <1%
Country · Poland3,562 / 496,512
Top <1%

Results vs voivodeship

Revenue
This companyUSD 79.16mMedianUSD 168.16kAverageUSD 3.49m
Net profit
This companyUSD 210.12kMedianUSD 3.97kAverageUSD 207.24k
Operating costs
This companyUSD 78.13mMedianUSD 141.78kAverageUSD 3.16m
Assets
This companyUSD 60.78mMedianUSD 157.07kAverageUSD 3.56m

Websites

Public procurement

4 tenders recorded as contractor: 3 national ($194,248) and 1 EU ($61,286), and 582 as contracting authority (244 national and 338 EU).

SubjectAmount
Drug programme – treatment of patients with limb spasticity using botulinum toxin type A; medicines under the drug programme – treatment of patients with limb spasticity using botulinum toxin type A
$17,796
Drug programme – preventive treatment of patients with chronic migraine; medicines under the drug programme – preventive treatment of patients with chronic migraine
$43,490
Pharmaceutical service involving the preparation of parenteral nutrition mixtures
$107.1K

National Health Fund (NFZ) contracts

The facility has been an NFZ healthcare provider since 2008. In 2026 it is performing 10 contracts with a total value of USD 86.74m. All its contracts were worth USD 738.84m in total.

NFZ contract value by year (in m USD)

Type of careNFZ branchContractsValue in 2026
Inpatient treatmentmałopolskie8USD 86.70m
Outpatient specialist caremałopolskie1USD 32.78k
Preventive health programmesmałopolskie1USD 1.36k

NFZ waiting lists

This company's facilities run 82 NFZ waiting lists. Waiting time forecast by NFZ, as of 17.11.2026.

ServiceWaiting time
Treatment of patients with atopic dermatitisno wait
Treatment of patients with severe alopecia areatano wait
Treatment of patients with severe alopecia areatano wait
Treatment of patients with chronic spontaneous urticariano wait
Treatment of patients with hidradenitis suppurativa (HS)no wait

Job offers

The facility lists 1 job opening on its own careers page: zeromski-szpital.pl/kariera.

Position
Epidemiology specialist

Beneficial owners

No beneficial owners recorded for the entity Szpital Specjalistyczny Im. Stefana Żeromskiego Samodzielny Publiczny Zakład Opieki Zdrowotnej w Krakowie.

Bank accounts

Registered as a VAT taxpayer on 1999-01-25.

  • Bank Gospodarstwa Krajowego
    Bank Gospodarstwa Krajowego
    84 1130 1150 0012 1148 7820 0029
  • Bank Gospodarstwa Krajowego
    Bank Gospodarstwa Krajowego
    41 1130 1150 0012 1148 7820 0027
  • Bank Gospodarstwa Krajowego
    Bank Gospodarstwa Krajowego
    10 1130 1150 0012 1148 7820 0003

Debt

No entries in the National Debtors Register (KRZ).

Public aid

59 public aid cases recorded, with a total value of $331,380.

PurposeGross amount
De minimis aid (in accordance with Commission Regulation 2023/2831)
$20,509
De minimis aid (in accordance with Commission Regulation 2023/2831)
$16,420
De minimis aid (in accordance with Commission Regulation 2023/2831)
$0

European Funds

5 projects recorded: 3 from FE lists ($801,552) and 2 Commission grants (FTS) ($294,017).

ProjectEU co-financing
Engineered cartilage from nose for the treatment of osteoarthritis (encanto)
$165K
Engineered cartilage from nose for the treatment of osteoarthritis (encanto)
$129K
Colorectal cancer prevention programme for people over 50 and those in specific high-risk groups.
$140.4K

Regulatory authorisations

AuthorityTypeStatus
Waste generation Active

FAQ

Last updated: 2026-04-01